Sign in
4

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001209191-16-113800

Chief Financial Officer acquired 5,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Bonner Michael Chief Financial Officer 2016-04-06 Grant or award +5,000 $4.34 $21,700 11,000 D
Loading xslF345X03/doc4.xml…